Hemostasis Today

March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
Mar 16, 2026, 18:42

Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke

Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Brett Cucchiara et al, published in Stroke:

”Exploring advances in antithrombotic therapy for noncardioembolic ischemic stroke: The OCEANIC-STROKE trial marks a significant development with its dual-pathway inhibition approach using asundexian alongside antiplatelet therapy.

Current evidence highlights the efficacy of antiplatelet monotherapy and, in certain scenarios, the superiority of dual-antiplatelet therapy shortly after an event.

However, the emerging promise of factor XI/XIa inhibitors could revolutionize secondary stroke prevention, potentially enhancing efficacy without increasing bleeding risks.

Dive into the latest findings and what they signify for future treatment directions.”

Title: Antithrombotic Therapy for Noncardioembolic Ischemic Stroke: Current Evidence and Future Directions

Authors: Brett Cucchiara, Jean M. Connors, Alejandro A. Rabinstein, Mukul Sharma

Read the Full Article on Stroke

Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke

Stay updated on all scientific advances with Hemostasis Today.